Literature DB >> 2828680

Attachment of human polymorphonuclear leukocytes to herpes simplex virus-infected fibroblasts mediated by antibody-independent complement activation.

J A van Strijp1, K P van Kessel, L A Miltenburg, A C Fluit, J Verhoef.   

Abstract

Herpes simplex virus (HSV)-infected cells can activate the human complement system without interference of specific anti-HSV antibodies. Analysis by flow cytometry showed that C3-like molecules were deposited on the membrane of the infected cell when incubated with human serum without specific antibodies. Depletion of calcium to block the classical pathway of the complement system had no effect on fluorescence intensity. The complement activation could be blocked by chelating both calcium and magnesium or by heating the serum. Furthermore, in the fluid phase C3 was converted to C3b by infected cells and not by uninfected cells. The antibody-independent activation did not lead to lysis of the virus-infected fibroblasts, indicating that the complement cascade is abrogated before formation of the membrane attack complex. This was also confirmed by measurement of the 50% hemolytic complement activities for total and alternative pathways. Polymorphonuclear leukocytes attached to infected fibroblasts after incubation of these fibroblasts with intact complement. This is most probably mediated by complement receptor binding of C3b and C3bi which is deposited on the membrane of the HSV-infected cell. Both type 1 and type 2 HSVs showed the same characteristics in complement activation and thereby mediated polymorphonuclear leukocyte adherence.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2828680      PMCID: PMC253641          DOI: 10.1128/JVI.62.3.847-850.1988

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  27 in total

1.  Activation of the alternative complement pathway by human B cell lymphoma lines is associated with Epstein-Barr virus transformation of the cells.

Authors:  I McConnell; G Klein; T F Lint; P J Lachmann
Journal:  Eur J Immunol       Date:  1978-07       Impact factor: 5.532

2.  Mutant analysis of herpes simplex virus-induced cell surface antigens: resistance to complement-mediated immune cytolysis.

Authors:  J C Glorioso; M Levine; T C Holland; M S Szczesiul
Journal:  J Virol       Date:  1980-09       Impact factor: 5.103

3.  Antibody-independent activation of the alternative complement pathway by measles virus-infected cells.

Authors:  J G Sissons; M B Oldstone; R D Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  1980-01       Impact factor: 11.205

4.  Mechanisms of recovery from viral infections: destruction of infected cells by neutrophils and complement.

Authors:  A S Grewal; B T Rouse; L A Babiuk
Journal:  J Immunol       Date:  1980-01       Impact factor: 5.422

5.  Defense mechanisms against bovine herpesvirus: relationship of virus-host cell events to susceptibility to antibody-complement cell lysis.

Authors:  L A Babiuk; R C Wardley; B T Rouse
Journal:  Infect Immun       Date:  1975-11       Impact factor: 3.441

6.  Measurement of antibody-mediated binding of human polymorphonuclear leukocytes to HSV-1 infected anchorage fibroblasts.

Authors:  K P Van Kessel; H J Van Kats-Renaud; J A Van Strijp; M R Visser; J Verhoef
Journal:  J Immunol Methods       Date:  1986-04-03       Impact factor: 2.303

7.  In vitro activation of feline complement by feline leukemia virus.

Authors:  L Kobilinsky; W D Hardy; R Ellis; S S Witkin; N K Day
Journal:  Infect Immun       Date:  1980-07       Impact factor: 3.441

8.  Complement-dependent, polymorphonuclear neutrophil-mediated cytotoxicity of herpesvirus-infected cells: possible mechanism(s) of cytotoxicity.

Authors:  A S Grewal; L A Babiuk
Journal:  Immunology       Date:  1980-06       Impact factor: 7.397

9.  Scanning and transmission electron microscopic studies of complement-mediated lysis and antibody-dependent cell-mediated cytolysis of herpes simplex virus-infected human fibroblasts.

Authors:  C A Daniels; S Bodner; K F Trofatter
Journal:  Am J Pathol       Date:  1980-09       Impact factor: 4.307

10.  Lysis of oncornaviruses by human serum. Isolation of the viral complement (C1) receptor and identification as p15E.

Authors:  R M Bartholomew; A F Esser; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1978-03-01       Impact factor: 14.307

View more
  13 in total

1.  Interferon-beta suppresses herpes simplex virus type 1 replication in trigeminal ganglion cells through an RNase L-dependent pathway.

Authors:  Daniel J J Carr; Khaldun Al-khatib; Cassandra M James; Robert Silverman
Journal:  J Neuroimmunol       Date:  2003-08       Impact factor: 3.478

2.  Complement-mediated phagocytosis of herpes simplex virus by granulocytes. Binding or ingestion.

Authors:  J A Van Strijp; K P Van Kessel; M E van der Tol; J Verhoef
Journal:  J Clin Invest       Date:  1989-07       Impact factor: 14.808

3.  Species selective interaction of Alphaherpesvirinae with the "unspecific" immune system of the host.

Authors:  H P Huemer; C Larcher; S van Drunen Littel-van den Hurk; L A Babiuk
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

4.  Antibody-independent classical complement pathway activation and homologous C3 deposition in xeroderma pigmentosum cell lines.

Authors:  M Kurita; M Matsumoto; S Tsuji; M Kawakami; Y Suzuki; H Hayashi; K Toyoshima; T Seya
Journal:  Clin Exp Immunol       Date:  1999-06       Impact factor: 4.330

5.  Pathogenicity of influenza viruses with genes from the 1918 pandemic virus: functional roles of alveolar macrophages and neutrophils in limiting virus replication and mortality in mice.

Authors:  Terrence M Tumpey; Adolfo García-Sastre; Jeffery K Taubenberger; Peter Palese; David E Swayne; Mary J Pantin-Jackwood; Stacey Schultz-Cherry; Alicia Solórzano; Nico Van Rooijen; Jacqueline M Katz; Christopher F Basler
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

Review 6.  I'm Infected, Eat Me! Innate Immunity Mediated by Live, Infected Cells Signaling To Be Phagocytosed.

Authors:  Tim Birkle; G C Brown
Journal:  Infect Immun       Date:  2021-04-16       Impact factor: 3.441

7.  Herpes simplex virus glycoprotein C: molecular mimicry of complement regulatory proteins by a viral protein.

Authors:  H P Huemer; Y Wang; P Garred; V Koistinen; S Oppermann
Journal:  Immunology       Date:  1993-08       Impact factor: 7.397

8.  A block in glycoprotein processing correlates with small plaque morphology and virion targetting to cell-cell junctions for an oral and an anal strain of herpes simplex virus type-1.

Authors:  J W Dick; K S Rosenthal
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

9.  Differential effect of murine alpha/beta interferon transgenes on antagonization of herpes simplex virus type 1 replication.

Authors:  Peter Härle; Vanessa Cull; Martin-Paul Agbaga; Robert Silverman; Bryan R G Williams; Cassandra James; Daniel J J Carr
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

10.  Neutrophil-mediated suppression of virus replication after herpes simplex virus type 1 infection of the murine cornea.

Authors:  T M Tumpey; S H Chen; J E Oakes; R N Lausch
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.